Literature DB >> 14571819

Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.

Masahiko Yamaguchi1, Takemasa Midorikawa, Mitsuo Saitoh, Shigeki Kadokura, Kiyoshi Miyagawa, Yutaka Sanada, Kaoru Kumada.   

Abstract

A 72-year-old man was referred with an endoscopic diagnosis of Borrmann 2 type advanced gastric cancer. Further examination revealed tumor thrombus in the splenic vein and high serum level of alpha-fetoprotein without liver disease. Intraoperative ultrasonography revealed that tumor thrombus originated from gastric cancer extended to the splenic vein through the left gastric vein. Total gastrectomy combined with distal pancreatectomy and splenectomy was done to obtain complete resection of cancer and tumor thrombus. Tumor and its thrombus in the splenic vein were diagnosed as a poorly differentiated adenocarcinoma that produced alpha-fetoprotein. We report the case, and discuss about the gastric cancer with portal tumor thrombus and high serum levels of alpha-fetoprotein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14571819

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Successful treatment of advanced gastric adenocarcinoma with portal tumor thrombosis by total gastrectomy following CDDP and S-1 therapy.

Authors:  Sumiya Ishigami; Takaaki Arigami; Keishi Okubo; Ken Sasaki; Hiroshi Kurahara; Yoshikazu Uenosono; Hiroshi Okumura; Tetsuhiro Owaki; Yuko Kijima; Shinichi Ueno; Shoji Natsugoe
Journal:  Clin J Gastroenterol       Date:  2012-05-19

2.  A case of acinar cell carcinoma of the pancreas that formed extensive tumor thrombus of the portal vein.

Authors:  Hiroaki Igarashi; Sachiko Shinozaki; Takeo Mukada
Journal:  Clin J Gastroenterol       Date:  2008-12-05

3.  Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report.

Authors:  Shigetomi Nakao; Bunzo Nakata; Masashige Tendo; Kenji Kuroda; Takeshi Hori; Mayumi Inaba; Kosei Hirakawa; Tetsuro Ishikawa
Journal:  BMC Surg       Date:  2015-01-16       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.